Sarepta Therapeutics Outlines 2026 Priorities on Strong Cash Position FWRD Q1 2026 Earnings EPS Misses Estimates Stock Declines on Weak Profitability SonoTek Corporation Q4 2026 Earnings Call Highlights Financial Performance and Strategic Outlook